Cancer Rop Co. Ltd. (180400) — Financial Flexibility Index
Cancer Rop Co. Ltd. (180400) has a Financial Flexibility Index of -0.33x as of March 2026. Free cash flow of ₩-8.24 Billion (operating CF ₩-10.04 Billion minus capex ₩1.81 Billion) represents 0% of total liabilities (₩24.60 Billion). Check 180400 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cancer Rop Co. Ltd. Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Cancer Rop Co. Ltd. across 9 annual periods. See 180400 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cancer Rop Co. Ltd. (2014–2025)
Year-by-year free cash flow to debt coverage for Cancer Rop Co. Ltd.. For the full company profile including market capitalisation, see Cancer Rop Co. Ltd. (180400) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.30x | ₩-17.44 Billion | ₩-18.85 Billion | ₩59.11 Billion | ▲ +13.9% |
| 2024 | -0.34x | ₩-19.19 Billion | ₩-20.03 Billion | ₩56.00 Billion | ▼ -146.8% |
| 2023 | -0.14x | ₩-9.88 Billion | ₩-12.06 Billion | ₩71.14 Billion | ▼ -375.1% |
| 2022 | 0.05x | ₩2.60 Billion | ₩865.55 Million | ₩51.60 Billion | ▲ +312.1% |
| 2018 | -0.02x | ₩-776.69 Million | ₩-4.94 Billion | ₩32.64 Billion | ▼ -185.7% |
| 2017 | -0.01x | ₩-187.26 Million | ₩-2.14 Billion | ₩22.49 Billion | ▲ +99.5% |
| 2016 | -1.59x | ₩-1.02 Billion | ₩-1.50 Billion | ₩644.52 Million | ▼ -61.6% |
| 2015 | -0.98x | ₩-603.75 Million | ₩-841.17 Million | ₩614.80 Million | ▼ -146.7% |
| 2014 | 2.10x | ₩1.10 Billion | ₩783.83 Million | ₩522.87 Million | — |